Guildford, UK, 21 November 2012: ReNeuron will announce its interim results for the six months ended 30 September 2012 on Tuesday 4 December 2012.
Notification of Interim Results
ReNeuron announces further progress with stroke clinical trial. All three patients in penultimate dose cohort successfully treated
Guildford, UK, 17 October 2012: ReNeuron provides an update on progress with the PISCES clinical trial of its ReN001 stem cell therapy for disabled stroke patients.
Results of 2012 Annual General Meeting
Guildford, UK, 11 September 2012: ReNeuron announces that all resolutions put to its shareholders at today’s Annual General Meeting were passed.
ReNeuron files two new clinical trial applications ahead of plan in stroke and critical limb ischaemia as its stem cell programmes advance
Guildford, UK, 11 September 2012: ReNeuron provides a trading update ahead of today’s Annual General Meeting.
ReNeuron receives DSMB clearance to progress to higher dose in stem cell clinical trial in disabled stroke patients: First patient treated in this higher dose cohort
Guildford, UK, 14 August 2012: ReNeuron provides an update on progress with the PISCES clinical trial of its ReN001 stem cell therapy for disabled stroke patients.
Posting of Annual Report & Accounts and Notice of AGM 2012
Guildford, UK, 16 July 2012: ReNeuron announces that its Annual Report and Accounts for the year ended 31 March 2012 and the Notice of the 2012 Annual General Meeting (“AGM”) have been sent to shareholders and are also available on the Company’s website at www.reneuron.com.
Webcast of 2012 Preliminary Results to Analysts
Please click on link below for webcast of 2012 Preliminary results presentation to analysts
ReNeuron announces establishment of Scientific and Strategic Advisory Group and non-executive Board changes
Guildford, UK, 28 June 2012: ReNeuron is pleased to announce the establishment of its Scientific and Strategic Advisory Group.
Preliminary Results for the Year Ended 31 March 2012
ReNeuron announces preliminary results for the year ended 31 March 2012
Notification of Preliminary Results
Guildford, UK, 1 July 2013: ReNeuron will announce its preliminary results for the year ended 31 March 2013 on Thursday 25 July 2013.